December 10, 2015
CTI Clinical Trial & Consulting Services Presents at Cincinnati Bar Association Seminar on Health Care Law
FOR IMMEDIATE RELEASE [Cincinnati, OH ~ December 10, 2015]
CTI Clinical Trial and Consulting Services (CTI) is presenting at the Cincinnati Bar Association’s continuing legal education seminar on Health Care Law, taking place December 10th. CTI’s Candace Gunnarsson, EdD, Vice President, Health Economics and Outcomes Research will speak as part of the seminar on ‘Health Economics and Outcomes Research – What’s the Value?'.
“I am very excited to be a part of this seminar, as health care is a rapidly changing field where data, economic analyses, and outcomes research are playing an increasing role, with CTI working directly on a variety of projects in these areas on behalf of health care systems, payers, and pharmaceutical/medical device companies,” according to Dr. Gunnarsson.
Dr. Gunnarsson has over 30 years of statistical and health economics experience. She leads a multitude of projects in Health Outcomes and Economics, including data mining, statistical analyses, and economic evaluation services. Prior to joining CTI, Dr. Gunnarsson was Founder and President of S2 Statistical Solutions, Inc., which was acquired by CTI in 2013, and she spent over ten years teaching undergraduate and graduate statistics courses in the fields of education, psychology, and business at Xavier University, The Union Institute, and the University of Cincinnati. She currently teaches at Xavier University as a part of their new HECOR Master’s Degree program. Dr. Gunnarsson received her Doctor of Education degree with Data Sciences Certification from the University of Cincinnati.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com